ESC 2015
Find the most relevant articles from ESC Congress 2015. August 29 - September 02, London, UK
OPTIDUAL: Dual Antiaggregation Not Beneficial after 12 Months.
Extending dual antiaggregation therapy (DAT) from 12 to 48 months appears not to offer extra protection after DES implantation in patients with no adverse ischemic events during the first year, ...
Extending dual antiaggregation therapy (DAT) from 12 to 48 months appears not to offer extra protection after DES implantation in patients with no adverse ischemic events during the first year, ...
Meta-analysis of prolonged DAT after DES
Extending the antiaggregation therapy over a year reduces adverse events in patients with a history of AMI, according to this meta-analysis simultaneously published in the European Heart ...
Extending the antiaggregation therapy over a year reduces adverse events in patients with a history of AMI, according to this meta-analysis simultaneously published in the European Heart ...
FAME at 5 years: FFR Should Guide All Multivessel PCIs
Though the benefit of FFR (fractional flow reserve) over angiography is statistically important only over the first 2 years, this pattern is maintained at long term according to FAME 5 year follow ...
Though the benefit of FFR (fractional flow reserve) over angiography is statistically important only over the first 2 years, this pattern is maintained at long term according to FAME 5 year follow ...
BACC: Protocol for Rapid Diagnosis of Myocardial Infraction
The 1-hour algorithm using high-sensitivity troponin measurement for rapid diagnosis of AMI is safe.To carry out the BACC study (Biomarkers in Acute Cardiovascular Care) the effects of the ...
The 1-hour algorithm using high-sensitivity troponin measurement for rapid diagnosis of AMI is safe.To carry out the BACC study (Biomarkers in Acute Cardiovascular Care) the effects of the ...